Home/ Supplements/ Electrolytes/ Liqui-Mag Maple Vanilla

Liqui-Mag Maple Vanilla

product on market Liquid Brainchild Nutritionals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Magnesium is the primary active ingredient, with strong evidence supporting its role in muscle function and nervous system regulation. Other listed components are basic macronutrients and minerals with well-established safety profiles. Overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Liqui-Mag Maple Vanilla
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Teaspoon(s)
Serving Size
48
Servings
Mineral
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Sodium
5 mg (1% DV)
Total Carbohydrates
3 Gram(s) (1% DV)
150 mg (38% DV)
Within RDA (0.4× RDA) 316 studies (A:8, B:159)

Other Ingredients

Water, Purified Xanthan Gum Glycerin Vanilla Potassium Sorbate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, take 2 teaspoons 1-3 times a day, with or without food. May be mixed with water or other beverages. If loose stools occur, split into smaller doses or reduce dosage.

Formulation Notes

Does not contain eggs, wheat, gluten, dairy, casein, yeast, corn, soy, refined sugars, artificial sweeteners, colors or flavors. Every effort has been taken to eliminate any significant sources of natural salicylates, phenols and benzoates.

Exceptionally well-absorbed liquid magnesium supplement

Amino acid chelates ad complexes are highly bioavailable forms of minerals. Minerals are bonded with organic acids of the krebs cycle, or amino acids, for better absorption.

Additional Information

Refrigerate after opening use within 3 months

Metadata

Product Details

UPC / SKU8 13348 01138 2
DSLD Entry Date2025-08-22
Product TypeMineral
FormLiquid
DSLD ID329416
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.